Klaus Charisse
41Patents
8h-index
36Co-inventors
71Inventor score
Filing activity: Sep 22, 2010 → May 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9796974B2 | Modified RNAi agents | Chemistry; Metallurgy | 85 | Active |
| US9399775B2 | RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases | Chemistry; Metallurgy | 29 | Active |
| US9783806B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 13 | Active |
| US9127274B2 | Serpinc1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 12 | Active |
| US11504391B1 | Modified RNA agents with reduced off-target effect | Chemistry; Metallurgy | 12 | Active |
| US9249415B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 11 | Active |
| US9574192B2 | Serapina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 10 | Active |
| US10668170B2 | Modified RNAi agents | Chemistry; Metallurgy | 8 | Active |
| US10238749B2 | Angiotensinogen (AGT) iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 8 | Active |
| US10570391B2 | RNAi agents, compositions and methods of use thereof for treating transthyretin (TTR) associated diseases | Chemistry; Metallurgy | 8 | Active |
| US10995336B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US9701963B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US10030244B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US9850488B2 | Complement component C5 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US9376680B2 | Serpinc1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10913950B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10125369B2 | PCSK9 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US9068184B2 | Compositions and methods for inhibition of expression of protein C (PROC) genes | Chemistry; Metallurgy | 3 | Active |
| US11406716B2 | Modified RNAi agents | Chemistry; Metallurgy | 3 | Active |
| US11597932B2 | Chirally-enriched double-stranded RNA agents | Chemistry; Metallurgy | 3 | Active |
| US10920223B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US9970006B2 | Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes | Chemistry; Metallurgy | 2 | Active |
| US10988768B2 | TMPRSS6 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US9315813B2 | Compositions and methods for inhibition of expression of apolipoprotein C-III (APOC3) genes | Chemistry; Metallurgy | 2 | Active |
| US10683504B2 | Serpina1 iRNA compositions and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.